News
Adjuvant camrelizumab and concurrent chemoradiotherapy can improve outcomes in patients with gallbladder cancer and extrahepatic cholangiocarcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback